Shopping Cart 0
Cart Subtotal
AED 0

Living Cell Technologies Ltd (LCT) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 2753

Details

Summary

Living Cell Technologies Ltd (LCT) is a biotechnology company that develops cell-based therapeutics for the treatment of neurological diseases, diabetes, and stroke and hearing loss. It focuses on discovering regenerative treatments which restore function using naturally occurring cells. LCT develops its candidates based on its proprietary encapsulation technology, Immupel. Its lead product candidate, NTCELL is an alginate coated capsule containing clusters of neonatal porcine choroid plexus cells. It is in Phase IIb clinical trials for the treatment of Parkinson's disease. The company is also developing the candidate in a number of other central nervous system indications, including Huntington's, Alzheimer's and motor neurone diseases including amyotrophic lateral sclerosis (ALS). LCT's joint venture, Diatranz Otsuka Limited develops Diabecell, a cell therapy for type 1 diabetes. LCT is headquartered in Auckland, the New Zealand.

Living Cell Technologies Ltd (LCT)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Living Cell Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Living Cell Technologies Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Living Cell Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Living Cell Technologies Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Living Cell Technologies Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Living Cell Technologies Ltd, Medical Equipment, Deal Details 10

Equity Offering 10

Living Cell Technologies to Raise Funds through Share Purchase Plan 10

Living Cell Technologies Raises USD2.8 Million in Private Placement of Shares 11

Acquisition 12

Otsuka Pharma to Acquire 50% Stake in Diatranz Otsuka from Living Cell Technologies for USD3 Million 12

Living Cell Technologies Ltd-Key Competitors 13

Living Cell Technologies Ltd-Key Employees 14

Living Cell Technologies Ltd-Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Joint Venture 16

Recent Developments 17

Financial Announcements 17

Jul 26, 2018: Living Cell Technologies: Appendix 4C Quarterly Cash Flow Report 30 June 2018 17

Aug 23, 2017: Living Cell Technologies: Preliminary Final Report 30 June 2017 18

Jul 20, 2017: Living Cell Technologies: Appendix 4C Quarterly Cash Flow Report 30 June 2017 19

Corporate Communications 20

Aug 31, 2018: Living Cell Technologies: Roy Austin has stepped down from his role as Chairman and from his post 20

Other Significant Developments 21

Apr 11, 2018: LCT Strategy Update 21

Oct 18, 2017: Living Cell Technologies: Quarterly Cash Flow Report 30 September 2017 23

Appendix 24

Methodology 24

About GlobalData 24

Contact Us 24

Disclaimer 24


List Of Figure

List of Figures

Living Cell Technologies Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Living Cell Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Living Cell Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Living Cell Technologies Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Living Cell Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Living Cell Technologies Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Living Cell Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Living Cell Technologies Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Living Cell Technologies Ltd, Medical Equipment, Key Facts, 2018 2

Living Cell Technologies Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Living Cell Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Living Cell Technologies Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Living Cell Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Living Cell Technologies Ltd, Deals By Market, 2012 to YTD 2018 8

Living Cell Technologies Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Living Cell Technologies to Raise Funds through Share Purchase Plan 10

Living Cell Technologies Raises USD2.8 Million in Private Placement of Shares 11

Otsuka Pharma to Acquire 50% Stake in Diatranz Otsuka from Living Cell Technologies for USD3 Million 12

Living Cell Technologies Ltd, Key Competitors 13

Living Cell Technologies Ltd, Key Employees 14

Living Cell Technologies Ltd, Subsidiaries 15

Living Cell Technologies Ltd, Joint Venture 16

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Living Cell Technologies Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Living Cell Technologies Ltd (LCT) is a biotechnology company that develops cell-based therapeutics for the treatment of neurological diseases, diabetes, and stroke and hearing loss. It focuses on discovering regenerative treatments which restore function using naturally occurring cells. LCT develops its candidates based on its proprietary encapsulation technology, Immupel. Its lead product candidate, NTCELL is an alginate coated capsule containing clusters of neonatal porcine choroid plexus cells. It is in Phase IIb clinical trials for the treatment of Parkinson's disease. The company is also developing the candidate in a number of other central nervous system indications, including Huntington's, Alzheimer's and motor neurone diseases including amyotrophic lateral sclerosis (ALS). LCT's joint venture, Diatranz Otsuka Limited develops Diabecell, a cell therapy for type 1 diabetes. LCT is headquartered in Auckland, the New Zealand.

Living Cell Technologies Ltd (LCT)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Living Cell Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Living Cell Technologies Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Living Cell Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Living Cell Technologies Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Living Cell Technologies Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Living Cell Technologies Ltd, Medical Equipment, Deal Details 10

Equity Offering 10

Living Cell Technologies to Raise Funds through Share Purchase Plan 10

Living Cell Technologies Raises USD2.8 Million in Private Placement of Shares 11

Acquisition 12

Otsuka Pharma to Acquire 50% Stake in Diatranz Otsuka from Living Cell Technologies for USD3 Million 12

Living Cell Technologies Ltd-Key Competitors 13

Living Cell Technologies Ltd-Key Employees 14

Living Cell Technologies Ltd-Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Joint Venture 16

Recent Developments 17

Financial Announcements 17

Jul 26, 2018: Living Cell Technologies: Appendix 4C Quarterly Cash Flow Report 30 June 2018 17

Aug 23, 2017: Living Cell Technologies: Preliminary Final Report 30 June 2017 18

Jul 20, 2017: Living Cell Technologies: Appendix 4C Quarterly Cash Flow Report 30 June 2017 19

Corporate Communications 20

Aug 31, 2018: Living Cell Technologies: Roy Austin has stepped down from his role as Chairman and from his post 20

Other Significant Developments 21

Apr 11, 2018: LCT Strategy Update 21

Oct 18, 2017: Living Cell Technologies: Quarterly Cash Flow Report 30 September 2017 23

Appendix 24

Methodology 24

About GlobalData 24

Contact Us 24

Disclaimer 24


List Of Figure

List of Figures

Living Cell Technologies Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Living Cell Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Living Cell Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Living Cell Technologies Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Living Cell Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Living Cell Technologies Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Living Cell Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Living Cell Technologies Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Living Cell Technologies Ltd, Medical Equipment, Key Facts, 2018 2

Living Cell Technologies Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Living Cell Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Living Cell Technologies Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Living Cell Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Living Cell Technologies Ltd, Deals By Market, 2012 to YTD 2018 8

Living Cell Technologies Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Living Cell Technologies to Raise Funds through Share Purchase Plan 10

Living Cell Technologies Raises USD2.8 Million in Private Placement of Shares 11

Otsuka Pharma to Acquire 50% Stake in Diatranz Otsuka from Living Cell Technologies for USD3 Million 12

Living Cell Technologies Ltd, Key Competitors 13

Living Cell Technologies Ltd, Key Employees 14

Living Cell Technologies Ltd, Subsidiaries 15

Living Cell Technologies Ltd, Joint Venture 16

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Living Cell Technologies Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.